Safety and activity of alectinib plus bevacizumab in patients with advanced ALK-rearranged non-small-cell lung cancer: a phase I/II study

por Lin, J.J., Muzikansky, A., Kennedy, E., Kuberski, H., Stober, L.L., Wanat, A.C., Azzoli, C.G., Lennes, I., Sequist, L.V., Dagogo-Jack, I., Shaw, A.T., Gainor, J.F.
Publicado 2021

Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma

por Krug, A K, Enderle, D, Karlovich, C, Priewasser, T, Bentink, S, Spiel, A, Brinkmann, K, Emenegger, J, Grimm, D G, Castellanos-Rizaldos, E, Goldman, J W, Sequist, L V, Soria, J -C, Camidge, D R, Gadgeel, S M, Wakelee, H A, Raponi, M, Noerholm, M, Skog, J
Publicado 2018